Literature DB >> 12091346

Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfaces.

Julie A Oliver1, Dougald M Monroe, Frank C Church, Harold R Roberts, Maureane Hoffman.   

Abstract

The protein C/protein S system is known to regulate thrombin generation in vivo by cleaving factors Va and VIIIa. We have examined the activity of activated protein C in several tissue factor-initiated models of coagulation. We used 4 models: monocytes as the tissue factor source with platelets as the thrombin-generating surface; endothelial cells as the tissue factor source with platelets as the thrombin-generating surface; endothelial cells as both the tissue factor source and the thrombin-generating surface; and relipidated tissue factor with lipid vesicles providing the surface for thrombin generation. With the lipid surface, activated protein C dose-dependently reduced thrombin generation. Similarly, when endothelial cells provided the only surface for thrombin generation, activated protein C dose-dependently decreased thrombin generation significantly. By contrast, whenever platelets were present, activated protein C only minimally affected the amount of thrombin generated. When endothelial cells were the tissue factor source with platelets providing the surface for thrombin generation, activated protein C did increase the time until the burst of thrombin generation but had minimal effects on the total amount of thrombin generated. Activated protein C had essentially no effect on thrombin generation when monocytes were the tissue factor source with platelets providing the surface for thrombin generation. From the studies reported here, we conclude that in vivo, despite the important role of the protein C system in regulating thrombosis, activated protein C does not serve as a primary regulator of platelet-dependent thrombin generation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091346     DOI: 10.1182/blood.v100.2.539

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Crystal structure of Jararacussin-I: the highly negatively charged catalytic interface contributes to macromolecular selectivity in snake venom thrombin-like enzymes.

Authors:  A Ullah; T A C B Souza; L M Zanphorlin; R B Mariutti; V S Santana; M T Murakami; R K Arni
Journal:  Protein Sci       Date:  2013-01       Impact factor: 6.725

2.  Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma.

Authors:  Laura D Gray; Michael A Hussey; Brittany M Larson; Kellie R Machlus; Robert A Campbell; Gary Koch; Mirella Ezban; Ulla Hedner; Alisa S Wolberg
Journal:  Thromb Res       Date:  2011-05-10       Impact factor: 3.944

Review 3.  Portal vein thrombosis in cirrhosis.

Authors:  Kaiser Raja; Mathew Jacob; Sonal Asthana
Journal:  J Clin Exp Hepatol       Date:  2013-12-31

4.  Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants.

Authors:  Hsiu-Hui Chen; Cristina P Vicente; Li He; Douglas M Tollefsen; Tze-Chein Wun
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

Review 5.  Activated protein C in sepsis: the promise of nonanticoagulant activated protein C.

Authors:  Hartmut Weiler; Wolfram Ruf
Journal:  Curr Opin Hematol       Date:  2008-09       Impact factor: 3.284

Review 6.  Remodeling the blood coagulation cascade.

Authors:  Maureane Hoffman
Journal:  J Thromb Thrombolysis       Date:  2003 Aug-Oct       Impact factor: 2.300

7.  Systemic blood coagulation activation in acute coronary syndromes.

Authors:  Anetta Undas; Konstanty Szułdrzyński; Kathleen E Brummel-Ziedins; Wiesława Tracz; Krzysztof Zmudka; Kenneth G Mann
Journal:  Blood       Date:  2008-10-17       Impact factor: 22.113

Review 8.  Coagulation Pathways in Neurological Diseases: Multiple Sclerosis.

Authors:  Nicole Ziliotto; Francesco Bernardi; Dejan Jakimovski; Robert Zivadinov
Journal:  Front Neurol       Date:  2019-04-24       Impact factor: 4.003

Review 9.  Interactions between the innate immune and blood coagulation systems.

Authors:  Charles T Esmon
Journal:  Trends Immunol       Date:  2004-10       Impact factor: 16.687

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.